Norway not only has a rich source of oil but has a rich supply of real world data sources (RWDs), especially when in concerns oncology! Such registries have been used for a number of studies and publications. This is especially the case for Norway’s oncology registries, of which there are many high-quality datasets.
The table below displays the Norwegian National and Quality disease registries specific to Oncology currently available.
High Impact Articles
Some of which have had their quality assessed in validation studies, these are further described in our previous blog post. This can also be supported by the number of registry-related articles found in high impact publications, as shown in the graph below, displaying the number of publications at each category of impact factor. Most publications were found in journals with an impact factor of 2 to 4.
Sample high impact publications from selected registries:
Norwegian Cancer Registry
- Kharazmi E, Hemminki K, Pukkala E, Sundquist K, Tryggvadottir L, Tretli S, et al. Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries. Eur Urol. 2015 Aug;68(2):283–9.
- Scelo G, Muller DC, Riboli E, Johannson M, Cross AJ, Vineis P, et al. KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study. Clin Cancer Res. 2018 Jul 23;
- Lüchtenborg M, Morris EJA, Tataru D, Coupland VH, Smith A, Milne RL, et al. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer. Thorax. 2018 Apr;73(4):339–49.
National Quality Register for Childhood Cancer
- Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol. 2014 Jan;15(1):35–47.
National Quality Register for Lung Cancer
- Nilssen Y, Strand TE, Fjellbirkeland L, Bartnes K, Møller B. Lung cancer survival in Norway, 1997-2011: from nihilism to optimism. Eur Respir J. 2016 Jan;47(1):275–87.
National Quality Register for Prostate Cancer
- Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014 Feb;65(2):303–13.
- Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014 Mar 6;370(10):932–42.
- Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015 Jan 20;33(3):272–7.
- Fossati N, Willemse P-PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017;72(1):84–109.
- Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med. 2016 13;375(15):1415–24.
We will also be releasing more posts relating to the RWDs of Norway, so remember to look out for them. If you would like to get more information about RWE and country sources, sign up to our monthly newsletter today!